New therapeutic target for Crohn’s disease

A promising new target for future drugs to treat inflammatory bowel disease (IBD) has been uncovered by researchers. The study also indicates that another protein, protein kinase C (PKC) ?/?, may serve as a biomarker of IBD severity.